Lisa Stamp, MBChB, PhD, is here to help the busy clinician by curating a collection of the most significant and notable abstracts in gout research to be presented at ACR Convergence 2024.
Research in Psoriatic Arthritis Most Likely to Make a Difference to Clinical Care
What research on psoriatic arthritis to be presented at ACR Convergence 2024 has the greatest potential for a positive impact on clinical care, treatment options or serve as the basis for future research? That’s the question The Rheumatologist asked David S. Pisetsky, MD, PhD—our founding editor—to consider. With thousands of research abstracts to be presented…
Measures of Success
Can a treat-to-target strategy achieve better outcomes for patients with spondyloarthritis? Insights from the latest data.
Fracture & an Aging World
Insights into osteoporosis treatments as societies around the world age.
A Long Path Forward: Complications of COVID-19 in Patients with Rheumatic Disease
Emerging evidence shows COVID-19 infection may have long-term consequences, such as arthritis onset and more.
Plan Ahead: Clinical Tips for Managing Reproductive Health in Patients with Rheumatic Disease
Dr. May Ching Soh highlighted practical approaches when caring for pregnant patients with rheumatic disease.
Ways You Can Be a Rheumatology Advocate at ACR Convergence 2024
As you make your plans to attend ACR Convergence 2024, keep in mind that the ACR advocacy team will host several events and programs throughout the week. If you have any questions, get in touch with our team at [email protected]. RheumPAC Lounge & Donor Event Investing in RheumPAC is a great way to support the…
Axial Spondyloarthritis: Research that Matters
Axial spondyloarthritis (axSpA), comprising ankylosing spondylitis (AS) and nonradiographic axial SpA, is the main form of chronic inflammatory arthritis affecting the axial skeleton. What research in axial spondyloarthrits to be presented at ACR Convergence 2024 has the greatest potential for a positive impact on clinical care, treatment options or serve as the basis for future…
ACR-Led Coalition Working Toward Legislative Solutions for Underwater Biosimilars
The Underwater Biosimilars Coalition will meet with the Medicare Payment Advisory Commission to discuss concerns about inadequate reimbursement for certain biosimilars, which has limited beneficiary access to these lower-cost alternative therapies.
Resources for Practices to Fight Payer Downcoding of E/M Services
The American Medical Association and ACR Insurance Subcommittee offer support and guidance to help practices recognize and push back against downcoded payments for evaluation and management services.
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 303
- Next Page »